Medtronic prevails over Boston Sci in patent suit

Medtronic has won a lawsuit it filed to prove it wasn't violating patents controlled by Boston Scientific. U.S. District Judge Sue Robinson in Wilmington, DE, said that Medtronic implantable defibrillators, including the InSync, Concerto and Consulta brands, weren't infringing two patents owned by Mirowski Family Ventures and licensed to Boston Scientific. She upheld the validity of the patents. Item

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.